Quest Diagnostics Inc (DGX) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 11.56B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $11.56B | (m) | (m) |
| 2026-03-31 | (m) | $11.28B | (m) | (m) |
| 2025-12-31 | (m) | $11.04B | (m) | (m) |
| 2025-09-30 | (m) | $10.85B | (m) | (m) |
| 2025-06-30 | (m) | $10.52B | (m) | (m) |
| 2025-03-31 | (m) | $10.16B | (m) | (m) |
| 2024-12-31 | (m) | $9.87B | (m) | (m) |
| 2024-09-30 | (m) | $9.54B | (m) | (m) |
| 2024-06-30 | (m) | $9.35B | (m) | (m) |
| 2024-03-31 | (m) | $9.29B | (m) | (m) |
| 2023-12-31 | (m) | $9.25B | (m) | (m) |
| 2023-09-30 | (m) | $9.30B | (m) | (m) |
| 2023-06-30 | (m) | $9.49B | (m) | (m) |
| 2023-03-31 | (m) | $9.60B | (m) | (m) |
| 2022-12-31 | (m) | $9.88B | (m) | (m) |
| 2022-09-30 | (m) | $10.29B | (m) | (m) |
| 2022-06-30 | (m) | $10.58B | (m) | (m) |
| 2022-03-31 | (m) | $10.68B | (m) | (m) |
| 2021-12-31 | (m) | $10.79B | (m) | (m) |
| 2021-09-30 | (m) | $11.05B | (m) | (m) |
| 2021-06-30 | (m) | $11.06B | (m) | (m) |
| 2021-03-31 | (m) | $10.34B | (m) | (m) |
| 2020-12-31 | $3.63B | $9.44B | (m) | 38.50% |
| 2020-09-30 | (m) | $8.36B | (m) | (m) |
| 2020-06-30 | (m) | $7.53B | (m) | (m) |
| 2020-03-31 | (m) | $7.66B | (m) | (m) |
| 2019-12-31 | $2.69B | $7.73B | (m) | 34.80% |
| 2019-09-30 | (m) | $7.64B | (m) | (m) |
| 2019-06-30 | (m) | $7.57B | (m) | (m) |
| 2019-03-31 | (m) | $7.54B | (m) | (m) |
| 2018-12-31 | $2.60B | $7.53B | (m) | 34.59% |
| 2018-09-30 | (m) | $7.86B | (m) | (m) |
| 2018-06-30 | (m) | $7.83B | (m) | (m) |
| 2018-03-31 | (m) | $7.78B | (m) | (m) |
| 2017-12-31 | $2.99B | $7.71B | (m) | 38.79% |
| 2017-09-30 | (m) | $7.63B | (m) | (m) |
| 2017-06-30 | (m) | $7.59B | (m) | (m) |
| 2017-03-31 | (m) | $7.55B | (m) | (m) |
| 2016-12-31 | $2.90B | $7.51B | (m) | 38.58% |
| 2016-09-30 | (m) | $7.50B | (m) | (m) |
| 2016-06-30 | (m) | $7.50B | (m) | (m) |
| 2016-03-31 | (m) | $7.52B | (m) | (m) |
| 2015-12-31 | $2.84B | $7.49B | (m) | 37.85% |
| 2015-09-30 | (m) | $7.53B | (m) | (m) |
| 2015-06-30 | (m) | $7.55B | (m) | (m) |
| 2015-03-31 | (m) | $7.53B | (m) | (m) |
| 2014-12-31 | $2.80B | $7.43B | (m) | 37.63% |
| 2014-09-30 | (m) | $7.31B | (m) | (m) |
| 2014-06-30 | (m) | $7.19B | (m) | (m) |
| 2014-03-31 | (m) | $7.11B | (m) | (m) |
| 2013-12-31 | $2.82B | $7.15B | (m) | 39.46% |
| 2013-09-30 | (m) | $7.16B | (m) | (m) |
| 2013-06-30 | (m) | $7.20B | (m) | (m) |
| 2013-03-31 | (m) | $7.26B | (m) | (m) |
| 2012-12-31 | $3.02B | $7.38B | (m) | 40.88% |
| 2012-09-30 | (m) | $7.57B | (m) | (m) |
| 2012-06-30 | (m) | $7.63B | (m) | (m) |
| 2012-03-31 | (m) | $7.63B | (m) | (m) |
| 2011-12-31 | $3.12B | $7.51B | (m) | 41.48% |
| 2011-09-30 | (m) | $7.46B | (m) | (m) |
| 2011-06-30 | (m) | $7.41B | (m) | (m) |
| 2011-03-31 | (m) | $7.38B | (m) | (m) |
| 2010-12-31 | $3.05B | $7.37B | (m) | 41.41% |
| 2010-09-30 | (m) | $7.39B | (m) | (m) |
| 2010-06-30 | (m) | $7.43B | (m) | (m) |
| 2010-03-31 | (m) | $7.45B | (m) | (m) |
| 2009-12-31 | (m) | $7.46B | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $7.25B | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | $6.70B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |